EP Patent

EP1125935A3 — Quinidine conjugates and their use in immunoassays

Assigned to Dade International Inc · Expires 2001-12-12 · 24y expired

What this patent protects

This invention relates to quinidine derivatives and immunogenic conjugates and reporter conjugates prepared therefrom. The immunogenic conjugates and reporter conjugates are useful for eliciting antibodies and for performing immunoassays for quinidine. A particle agglutination im…

USPTO Abstract

This invention relates to quinidine derivatives and immunogenic conjugates and reporter conjugates prepared therefrom. The immunogenic conjugates and reporter conjugates are useful for eliciting antibodies and for performing immunoassays for quinidine. A particle agglutination immunoassays for quinidine is also provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP1125935A3
Jurisdiction
EP
Classification
Expires
2001-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Dade International Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.